替莫唑胺治疗胶质母细胞瘤的近期不良反应观察
被引量:7
摘要
胶质母细胞瘤是常见的原发性中枢神经系统恶性肿瘤,其治疗方式是以包括手术、放疗及化疗的综合治疗。尽管经过数十年的临床努力,但患此恶性肿瘤的患者预后仍较差,生存期约为9—12个月。替莫唑胺(TMZ)作为一种新型的口服二代烷化剂类化疗药,在中枢神经系统可达到有效的药物浓度,是一种理想的脑胶质瘤化疗药物。
出处
《中华神经外科杂志》
CSCD
北大核心
2012年第7期693-695,共3页
Chinese Journal of Neurosurgery
参考文献15
-
1Zhang CZ, Zhang JX, Zhang AL, et al. MiR - 221 and miR -222 target PUMA to induce cell survival in glioblastoma. Mol Cancer,2010,9:229.
-
2Balducci M, D' Agostino GR, Manferida S, et al. Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas : long - term analysis of a phase Ⅱ study. J Neuroonco1,2010,97:95-100.
-
3Stupp R, Gander M,Leyvraz S,et al. Current and future developments in the use of temozolomide for the treatment of braintumours. Lancet Onco1,2001,2 :552-560.
-
4Koukourakis GV, Kouloulias V, Zacharias G, et al. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy ; a review article. Molecules ,2009,14 : 1561-1577.
-
5Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med ,2005,352:987-996.
-
6Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase Ⅲ study:5 - year analysis of the EORTC - NCIC trial. Lancet Oncol, 2009, 10:459-466.
-
7Trivedi RN, Almeida KH, Fornsaglio JL, et al. The role of base excision repair in the sensitivity and resistance to temozolomide - mediated cell death. Cancer Res ,2005,65:6394-6400.
-
8Viola G, Cecconet L, Leszl A,et al. Pyrrolotetrazinones deaza-analogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition. Cancer Chemother Pharmaco1,2009,64 : 1235-1251.
-
9Oh J, Kutas GJ, Davey P, et al. Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme. Curr Onco1,2010,17 : 124-126.
-
10Natelson EA, Pyatt D. Temozolomide - induced myelodysplasia. Adv Hematol,2010 ,2010 :760402.
二级参考文献19
-
1王能江,陈坚.原发性脑胶质瘤术后替莫唑胺化疗的临床观察[J].中华神经医学杂志,2007,6(5):500-502. 被引量:5
-
2Zhang C,Zhang J,Zhang A,et al.MiR-221 and miR-222 target PUMA to induce Cell survival in glioblastoma[.J]. Molecular Cancer,2010,9:229.
-
3Balducci M,D'Agostino GP Manfrida S,et al.Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase Ⅱ study[J].Neuro-Oncol,2010,97(1):95-100.
-
4Laperriere N,Zuraw L,Caimcross G.Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review[J].Radiother Oncol,2002,64(3):259-273.
-
5Grossman SA,O'Neill A,Grunnet M,et al.Phase Ⅲ study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with mewly diagnosed supratantorial glioblastoma multiforme: Eastern Cooperative Oncolgy Group Trial 2394[J].Clin Oncol,2003,21(8):1485-1491.
-
6Baker SD,Wirth M,Statkevich P,et al.Absorption,metabolism,and excretion of 14C-temozolonide following oral administration to patients with advanced cancer[J].Clin Cancer Res,1999,5(2):309-317.
-
7Trivedi RN,Almeida KH,Fornsaglio JL,et al.The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death[J].Cancer Res,2005,65(14):6394-6400.
-
8Stupp R,Mason WP,van den Bent MJ,et al.Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase Ⅲ study: 5-year analysis of the EORTC-NCIC trial[J].Lancet Oncol,2009,10(5):459-66.
-
9Theeler B J,Groves MD.High-grade gliomas[J].Curt Treat Options Neurol,2011,13(4):386-399.
-
10Stupp R, Hegi ME, Gilbert MR, et al. Chemoradiotherapy in malignant glioma: standard of care and future directions [J]. Clin Oncl, 2007, 25(26): 4127
共引文献15
-
1司绍永,仲任,孙立荣,徐慧娟,李学荣,庞秀英.伊立替康联合替莫唑胺对儿童难治性实体瘤近期疗效的研究[J].现代生物医学进展,2011,11(15):2948-2951. 被引量:4
-
2朱正权,刘亮,夏海成,孙哲.替莫唑胺治疗34例高级别胶质瘤的临床疗效观察[J].中国现代药物应用,2011,5(18):6-7. 被引量:2
-
3郑蓉,蒋德锡,廖心丹,张丹.温度及pH对替莫唑胺溶液稳定性的影响[J].华西药学杂志,2012,27(5):550-551. 被引量:1
-
4周渊,王汉东.替莫唑胺在胶质母细胞瘤化疗中的自噬作用研究进展[J].中华神经医学杂志,2012,11(10):1069-1072. 被引量:1
-
5温居一,蒋富强,王斌,张军,吴姗珊,康静波,聂青.术后放、化疗时序对高级别脑胶质瘤疗效的影响[J].中华神经医学杂志,2012,11(11):1143-1147. 被引量:5
-
6王小文,阳波,谢金龙.术后不同放化疗时间窗及程序对高级别脑胶质瘤疗效的影响[J].实用癌症杂志,2013,28(6):753-756. 被引量:3
-
7王跃飞,陈谦学,李明昌,陶红,高宇峰,王伟.替莫唑胺联合放疗治疗恶性胶质瘤有效性和安全性的Meta分析[J].中国医药导报,2014,11(23):71-75. 被引量:3
-
8王重韧,徐欣,尤宇,韩磊,赵四军,赵明.替莫唑胺联合放疗同步治疗胶质母细胞瘤的疗效观察[J].中国现代医生,2015,53(15):67-69. 被引量:1
-
9朱颂华,陆泳宇.替莫唑胺与司莫司汀对胶质母细胞瘤的临床疗效比较[J].河南医学研究,2015,24(12):18-20. 被引量:1
-
10黄冠又,张欣,明悦,曹楚南,甘鸿川.95例恶性胶质瘤患者术后生存情况及预后因素分析[J].重庆医学,2016,45(5):664-666. 被引量:9
同被引文献58
-
1曾宪起,申长虹,浦佩玉,杨树源.应用替莫唑胺对照司莫司丁治疗恶性脑胶质瘤的疗效观察[J].中华神经外科杂志,2006,22(4):204-207. 被引量:50
-
2曾宪起,申长虹,浦佩玉,杨树源.替莫唑胺与司莫司丁对恶性脑胶质瘤的疗效对比观察[J].中国临床神经外科杂志,2006,11(6):333-335. 被引量:8
-
3陈忠平.脑胶质瘤的临床治疗方向[J].中华神经外科杂志,2007,23(2):81-82. 被引量:36
-
4李乃卿,陶德胜,刘东来,魏永煜,谢海燕,毕国文,孙恒图,刘学华,谢伟宏,辛明,宋崇顺,史晓光,周柯鑫,胡淑毅,吴晓丽,陈茂如.参芪扶正注射液的新药研究[J].中国中西医结合杂志,2007,27(2):190-190. 被引量:4
-
5张罗生,刘智良,高兴旺,魏丽霞,郭雪霏,闵娜,贾彦征,廖洪.三维适形放疗联合替莫唑胺化疗对术后脑胶质瘤的疗效观察[J].中华神经医学杂志,2007,6(10):1005-1007. 被引量:11
-
6Yoshino A,Tashiro S,Ogino A. Gene expression profiles predicting the response to IFN-βand a combi-nation of temozolomide and IFN-βin malignant gliomas[J].{H}International Journal of Oncology,2011,(03):529-542.
-
7Ogawa K,Ishiuchi S,Inoue O. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine,nimustine,and vincristine) for high-grade gliomas:Long-term results[J].{H}International Journal of Radiation Oncology Biology Physics,2012,(02):732-738.
-
8周绍兵,刘阳晨,高飞,叶宏勋,赵莺,尹小祥.恶性脑胶质瘤术后替莫唑胺化疗联合适形放疗的疗效观察[J].现代肿瘤医学,2008,16(1):34-35. 被引量:9
-
9Stupp R,Hegi ME,Mason WP,et al. Effects of radiotherapy with con- comitant and adjuvant temozolomide versus radiotherapy alone on sur- vival in glioblastoma in a randomized phase Ⅲ study:5-year analysis of the EORTC-NCIC trial[J]. Lancet Oncol, 2009,10(5):459-466.
-
10何娅,张绍宇.替莫唑胺不良反应观察[J].中外健康文摘,2012,9(12):157-157.
引证文献7
-
1张海,刘阳,曾令勇,吴贵强,张波.脑胶质瘤术后行同步放化疗临床效果观察[J].中国实用神经疾病杂志,2014,17(1):60-62. 被引量:1
-
2程浩峰,何正文,任年军,杨杰.替莫唑胺治疗胶质瘤不良反应的观察及分析[J].中外医疗,2014,33(16):32-33. 被引量:1
-
3朱颂华,陆泳宇.替莫唑胺与司莫司汀对胶质母细胞瘤的临床疗效比较[J].河南医学研究,2015,24(12):18-20. 被引量:1
-
4苗发安,范月超.复发性胶质母细胞瘤再手术治疗预后因素分析[J].中国现代医生,2015,53(36):37-40. 被引量:2
-
5韦玮,曹慧琴,杨延庆.参芪扶正注射液配合替莫唑胺治疗恶性胶质瘤临床观察[J].神经损伤与功能重建,2016,11(4):354-355. 被引量:1
-
6王雪莹,张文镜,刘鑫,王锐.替莫唑胺致难治性神经母细胞瘤患儿癫痫发作1例[J].儿科药学杂志,2021,27(1).
-
7李小丽.胶质瘤术后呕吐原因分析及护理对策[J].大家健康(学术版),2014(21):211-211.
二级引证文献6
-
1卫昕伟.影响胶质母细胞瘤全切术后患者预后的相关因素分析[J].中外医疗,2016,35(21):108-110. 被引量:1
-
2陈侠,赖满香,冯娟,来慧丽,黄金凤.木犀草素对脑胶质瘤大鼠生长、血管生成及血管NF—kB表达水平的影响[J].中国心血管病研究,2017,15(2):186-189. 被引量:2
-
3罗清,陈芳,陈旭梅,冷远秀,胡威,李宁,邹彦,潘雅娜.WBRT±替莫唑胺对NSCLC脑转移疗效及安全性比较的Meta分析[J].中华放射肿瘤学杂志,2019,28(5):326-333. 被引量:5
-
4周相军,朱娜娜,李浩.神经外科治疗颅脑胶质瘤患者的生存状况研究[J].医学理论与实践,2021,34(8):1331-1333. 被引量:1
-
5余若楠,李婧.胶质瘤的中医诊治进展[J].中西医结合研究,2024,16(4):250-254.
-
6程浩峰,李春丽,任年军,杨杰.手术后同步放化疗治疗脑胶质瘤的临床效果观察[J].黑龙江医药,2014,27(6):1435-1437. 被引量:1
-
1李学,王增光,杨卫东,杨学军,杨树源,张建宁,岳树源.新型烷化剂替莫唑胺治疗胶质母细胞瘤的研究[J].中国保健,2010(2):11-13.
-
2贾佳,刘慧龙,王志忠.贝伐单抗治疗复发性脑胶质瘤研究进展[J].人民军医,2012,55(9):887-888.
-
3孙文栋,甘宁,刘思思,李春晖.胶质肉瘤1例[J].中国临床神经外科杂志,2015,20(6):356-356.
-
4魏风,成惠林.原发性中枢神经系统淋巴瘤误诊分析[J].山东医药,2007,47(32):139-139. 被引量:1
-
5魏新亭,杜伟,郑杰,秦晋辉.人脑胶质瘤耐药基因MGMT和NF-κB的表达及意义[J].中国实用神经疾病杂志,2008,11(10):8-10. 被引量:12
-
6刘丽峰,沙永生,赵晓亮.恩度联合NP方案治疗老年晚期非小细胞肺癌的不良反应观察及临床护理[J].护士进修杂志,2014,29(12):1118-1120. 被引量:15
-
7辛本茹,秦静.吉西他滨联合奥沙利铂治疗局部晚期胰腺癌的疗效及不良反应观察[J].中国医药指南,2013,11(34):472-473. 被引量:1
-
8邓婉芳,谢玉妍,徐建平.易瑞沙治疗晚期非小细胞肺癌患者的临床观察[J].中国医药指南,2012,10(22):158-159. 被引量:3
-
9杨金旗.替加氟对中晚期食管癌放疗增敏效果及不良反应观察[J].临床消化病杂志,2015,27(6):340-342. 被引量:4
-
10薛良军,冯艳,童文侠,陈意红.恶性胶质瘤术后辅助放疗同步替莫唑胺的临床观察[J].现代仪器与医疗,2015,21(4):22-24. 被引量:5